“a favorable trend”

Moreover, there is a favorable trend in AHT group, which may be due to improved reperfusion after thrombolysis.

For instance, support networks showed a mean rank of 8.69 in the intervention group versus 8.31 in the comparison group, and critical motivation showed a favorable trend (intervention mean rank = 9.63; comparison).

Recently, one study found that the presence of NAFLD showed a favorable trend on survival rates in CRC patients, although the data did not reach statistical significance ( P = 0.079), perhaps in part due to the small number of patients (227 patients) and poor statistical power. 20 Therefore, we aimed to design a large and more statistically robust cohort study to investigate the impact of NAFLD on the prognosis of patients with CRC.

The evidence suggests a favorable trend of physiotherapy on defecatory frequency, although with inter-study heterogeneity.

With a few exceptions (ACE inhibitors, antidiabetics, and statins), no pharmacological treatment showed a favorable trend (i.e., higher frequency in survivors); whereas, patients treated with aldosterone antagonists were significantly more frequent ( p < 0.001) in non-survivors (30.0% vs. 13.8%).

Conclusion: There is a favorable trend towards using conduits as prophylaxis of symptomatic neuroma formation since the nerves in which they were used showed fewer clinical signs of neuroma formation six months after surgery.

Further analysis revealed that both studies reported a favorable trend for cervical cancer patients with EGFR overexpression.

Further, a comparison of the change in utilization between the intervention and control groups showed a favorable trend, with a net reduction of 7 inpatient events and a net reduction of 14 emergency room (ER) visits in the 12‐month post‐index period. 4 Discussion Our study included 1042 Medicare beneficiaries who underwent PGx testing using a multi‐gene panel within a community‐based hospital system's primary care setting.

Although the superiority in PFS in the irAE group tended to attenuate at later landmark time points, a favorable trend was consistently observed across all analyses compared with the non‐irAE group.

Conclusions The K-Hammer technique improves operative efficiency, reduces pin insertion attempts, and demonstrates a favorable trend toward reduction in iatrogenic ulnar nerve injury risk (ARR 11.9%, NNT = 8.4), without compromising radiographic or functional outcomes.

37 – 41 Also, the proportion of subjects treated for arterial hypertension, dyslipidemia, or diabetes increased with age, but the chance of being controlled did not display a favorable trend.

In the ADAURA trial, patients with stage IB demonstrated a favorable trend in 5-year OS (94% vs 88%, hazard ratio [HR], 0.44; 95% CI, 0.17-1.02). 6 However, the magnitude and consistency of the benefit of adjuvant targeted therapy (ATT) in this subgroup remain ambiguous when compared with adjuvant chemotherapy (ACT) or placebo, particularly in terms of OS. 9 Emerging data

Our findings underscore the emerging role of postoperative immunotherapy as an independent predictor of longer OS and showed a favorable trend for improved iPFS, reinforcing data that immune-based therapies substantially contribute to both systemic and intracranial disease control in NSCLC-BM [ 29 , 30 ].

Our analysis consistently showed a favorable trend toward stabilization, as depicted in Figure 2E .

Ordinal logistic regression confirmed significant improvement with laser therapy per dermatologist ratings (odds ratio = 2.10, P = .019), with a favorable trend observed for fat grafting.

There was a favorable trend for CAS in perioperative stroke, myocardial infarction, and death in patients with high surgical risk such as restenosis after CEA. 28) On the other hand, CAS has disadvantages in the patients with severe arterial tortuosity and/or calcified lesion in comparison to CEA.

Among them, only three concluded that PTR did not confer an OS benefit [ 41 , 53 , 55 ], whereas 11 reported a significant OS advantage associated with PTR [ 40 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 ], and the remaining two suggested a favorable trend [ 42 , 54 ].

The mallet's inherent ability to osteocondensate the bone tissue may improve primary stability and indicates a favorable trend for secondary implant stability [ 23 ].

Subgroup results differed by modality; linked color imaging showed a favorable trend, but superiority remains unproven.

We found modest differences in timing of outcomes among patients monitored with real‐time results (non‐Holter), compared with those using traditional Holter test—in general and contrary to expected, real‐time ambulatory monitoring patients did not undergo cardiac procedures sooner and did not present to emergency department or hospitalization sooner, though there was a favorable trend toward earlier initiation of oral anticoagulation among patients with real‐time monitoring.

Although intervention within 24 h showed a favorable trend in severe cases, it did not significantly improve outcomes compared with 24–72 h. status released display-pdf yes is-in-collection-domain yes is-olf no is-manuscript no is-preprint no is-journal-matter no is-scanned no is-retracted no Revised 2025 Apr 23; Received 2025 Mar 9; Accepted 2025 May 9; Issue date 2025 Aug. 1.

The triplet group demonstrated a favorable trend in PSA-PFS, PFS2, and OS; however, a statistically significant difference was observed only for PSA-PFS.

One can see that the major contribution of CPM on thermodynamic results is the adsorption behaviors, i.e., enhanced N 2 adsorption and weakened NH 3 desorption, which implies a favorable trend to proceed with eNRR. , Such positive influences are mainly observed on 4d and 5d dopants of Groups 6–8.

While this finding may suggest a favorable trend in renal function, it should be interpreted with caution given the retrospective design and relatively short follow-up period.

There was also significantly less worsening in the hematology BILAG domain and a favorable trend in the vasculitis and renal domains. 29 Significant improvements were seen in both belimumab groups of BLISS-52 in the SFI flare rate and time to first flare, although the severe SFI flare rate and the rate of new BILAG 1A/2B scores at 52 weeks were significantly reduced only in the 10 mg/kg belimu